STOCK OPTIONS

6 Months Ended

Jun. 30, 2022

Share-Based Payment Arrangement [Abstract]

STOCK OPTIONS

NOTE 3 – STOCK OPTIONS

The following table presents the Company’s stock option activity for employees and directors of the Company for the year ended June 30, 2022:

	Number of Options		Weighted Average Exercise Price ($)
Outstanding at December 31, 2021		23,628,962		0.05
Granted		9,356,420		0.05
Exercised		-		-
Forfeited or expired		-		-
Outstanding at June 30, 2022		32,985,382		0.05
Number of options exercisable at June 30, 2022		19,798,655		0.05

The stock options outstanding as of June 30, 2022, have been separated into exercise prices, as follows:

Exercise price	Stock options outstanding		Weighted average remaining contractual life – years		Stock options vested
	As of June 30, 2022
0.0011		46,762				46,762
0.05		23,582,200		4.5		19,751,893
0.05		9,356,420		4.92		-
		32,985,382				19,798,655

Compensation expense recorded by the Company in respect of its stock-based compensation awards for the six and three months ended June 30, 2022 was $54 thousands and $27 thousands, respectively and are included in General and Administrative expenses in the Statements of Operations.

CITRINE GLOBAL, CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)